N Verses Capital, LLC Pacific Biosciences Of California, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 7,300 shares of PACB stock, worth $13,213. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,300Holding current value
$13,213% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
258Shares Held
234MCall Options Held
1.02MPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$60.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$47.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$42.7 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$42.3 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$30.3 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $407M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...